[Heart valve prosthesis, pregnancy and anticoagulant therapy].
The reproductive possibilities of cardiopathic patients with cardiac valvular prostheses have greatly improved in the past forty years. The correct management of this risk pregnancies remains a problem, however, especially as regards the chronic anticoagulant treatment to which these patients are subjected. The thirty years experience of a heart surgery-obstetric team is reported here. This included 14 pregnancies in women with aortic or mitral valvular prostheses. The problems relating to anticoagulant treatment in pregnancy and during labour are discussed.
Castino
P M
PM
Cattedra di Chirurgia Toracica, Università degli Studi di Chieti.
Actis Dato
A
A
Revelli
A
A
Porro
M C
MC
Actis Dato
G
G
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D001022:Aortic Valve Insufficiency / Q000601:surgery; D002585:Cesarean Section; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000601:surgery; D007744:Obstetric Labor Complications / Q000209:etiology; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000503:physiopathology*; D012307:Risk Factors
D000925:Anticoagulants
Protesi valvolari, gravidanza e terapia anticoagulante.